avatar

Auto-generated profile, based on publicly available information


Research Focus & Metrics

Representative Publications

View All Publications
7 June 2017 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
XHXiang He
Xiang He
SMShengli Ma
Shengli Ma
YTYinyin Tian
Yinyin Tian
CWCongwen Wei
Congwen Wei
YZYongjie Zhu
Yongjie Zhu
HZHui Zhong
Hui Zhong
Estrogen-related receptor α (ERRα) is a member of the nuclear receptor superfamily controlling energy homeostasis; however, its precise role in regulating antiviral innate immunity remains to be clarified. Here, we showed that ERRα deficiency conferred resistance to viral infection both in vivo and in vitro. Mechanistically, ERRα inhibited the production of type-I interferon (IFN-I) and the expression of multiple interferon-stimulated genes (ISGs). Furthermore, we found that viral infection induced TBK1-dependent ERRα stabilization, which in turn associated with TBK1 and IRF3 to impede the formation of TBK1-IRF3, IRF3 phosphorylation, IRF3 dimerization, and the DNA binding affinity of IRF3. The effect of ERRα on IFN-I production was independent of its transcriptional activity and PCG-1α. Notably, ERRα chemical inhibitor XCT790 has broad antiviral potency. This work not only identifies ERRα as a critical negative regulator of antiviral signaling, but also provides a potential target for future antiviral therapy. As a member of the nuclear receptor superfamily involved in metabolism signaling, the precise role of ERRα in antiviral innate immunity remains to be clarified. Here, we showed that ERRα deficiency led to increased interferon production, resulting in enhanced resistance to viral infection both in vivo and in vitro. Mechanistically, viral infection induced TBK1-dependent ERRα stabilization, which in turn increased its binding to TBK1 and IRF3 to prevent the formation of a functional TBK1-IRF3 complex. The effect of ERRα on IFN-I production was independent of its transcriptional activity and PCG-1α. Notably, ERRα chemical inhibitor XCT790 has broad antiviral potency. Taken together, our results identified ERRα as an important negative downstream regulator of TBK1 in RLRs-TLRs signaling pathways and suggested a potential therapeutic target for viral infection.

29 August 2023 in Frontiers in Immunology
Verified
Journal Article
Open access
YZYuping Zheng
Yuping Zheng
QHQingrui Huang
Qingrui Huang
YZYanfeng Zhang
Yanfeng Zhang
LGLanxin Geng
Lanxin Geng
WWWuqing Wang
Wuqing Wang
QLQiannan Li
Qiannan Li
Transient receptor potential (TRP) channels are a class of transmembrane proteins that can sense a variety of physical/chemical stimuli, participate in the pathological processes of various diseases and have attracted increasing attention from researchers. Recent studies have shown that some TRP channels are involved in the development of pathological scarification (PS) and directly participate in PS fibrosis and re-epithelialization or indirectly activate immune cells to release cytokines and neuropeptides, which is subdivided into immune inflammation, fibrosis, pruritus and mechanical forces increased. This review elaborates on the characteristics of TRP channels, the mechanism of PS and how TRP channels mediate the development of PS, summarizes the important role of TRP channels in the different pathogenesis of PS and proposes that therapeutic strategies targeting TRP will be important for the prevention and treatment of PS. TRP channels are expected to become new targets for PS, which will make further breakthroughs and provide potential pharmacological targets and directions for the in-depth study of PS.

22 November 2021 in Cancer Science
Verified
Journal Article
Open access
PDF file
FTFeiyu Tang
Feiyu Tang
FCFuyang Cao
Fuyang Cao
CLCan Lu
Can Lu
XHXiang He
Xiang He
LWLiang Weng
Liang Weng
LSLunquan Sun
Lunquan Sun
Colitis-associated colorectal cancer (CAC) arises due to prolonged inflammation and has distinct molecular events compared to sporadic colorectal cancer (CRC). Although inflammatory NF-κB signaling was activated by proinflammatory cytokines (such as TNFα) in early-stage of CAC, Wnt/β-catenin signaling later appears to function as a key regulator of CAC progression. However, the exact mechanism responsible for the cross-regulation between these two pathways remains unclear. Here, we found reciprocal inhibition between NF-κB and Wnt/β-catenin signalings in CAC samples, and the Dvl2, an adaptor protein of Wnt/β-catenin signaling, is responsible for NF-κB inhibition. Mechanistically, Dvl2 interacts with the C-terminus of TNFRI and mediates TNFRI endocytosis, leading to NF-κB signal inhibition. In addition, increased infiltration of the pro-inflammatory cytokine interleukin-13 (IL-13) is responsible for upregulating Dvl2 expression through STAT6. Targeting STAT6 effectively decreases Dvl2 level and restrains colony formation of cancer cells. These findings demonstrate a unique role for Dvl2 in TNFRI endocytosis, which facilitates the coordination of NF-κB and Wnt to promote CAC progression.